Advertisement

Site and Risk Factors of Antisperm Antibodies Production in the Male Population

  • Marcelo Marconi
  • Wolfgang Weidner
Chapter

Abstract

Inflammatory and/or infectious (inflammatory/infectious) diseases of the male reproductive tract (MRT), varicocele, genital trauma, testicular tumors, and testicular sperm extraction (TESE) between others have been proposed as risk factors for the generation of antisperm antibodies (ASA). However, as demonstrated in numerous clinical trials, the association between these entities and the presence of ASA is still controversial, indicating that the understanding of these conditions in the development of ASA is incomplete. However, there seems to be a consensus in the literature on three important facts: First, vasectomy followed by vasovasostomy (VV) is the only clinical condition that shows almost permanently high titers of ASA in numerous clinical series. Second, circulating ASA do not play an important role and do not show any negative influence on the fertility prognosis of the affected men. In contrast, local ASA act negatively on the motility of spermatozoa, on their ability to pass through the female genital secretions and/or on the fusion of gametes, which is the key event of fecundation. Third, the lack of a standardized method and an established cut-point for ASA detection in the ejaculate makes the comparison difficult among different clinical trials. Taking into account the increased prevalence of the above mentioned diseases in an uroandrological setting, this chapter evaluates the existing data trying to identify the possible risk factors and sites of ASA production in the MRT.

Keywords

Seminal Plasma Chlamydia Trachomatis Testicular Tumor Testicular Torsion Male Reproductive Tract 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

References

  1. 1.
    WHO (2000) World Health Organization manual for the standardized investigation and diagnosis of the infertile couple, 2nd edn. Cambridge University Press, CambridgeGoogle Scholar
  2. 2.
    Gubin DA, Dmochowski R, Kutteh WH (1998) Multivariant analysis of men from infertile couples with and without antisperm antibodies. Am J Reprod Immunol 39:157–160CrossRefPubMedGoogle Scholar
  3. 3.
    Jarow JP, Sanzone JJ (1992) Risk factors for male partners antisperm antibodies. J Urol 148:1805–1807PubMedGoogle Scholar
  4. 4.
    Lee R, Goldstein M, Ullery B, Ehrlich J, Soares M, Razzano R, Herman M, Callahan M, Li P, Schlegel P, Witkin S (2009) Value of serum antisperm antibodies in diagnosing obstructive azoospermia. J Urol 181:264–269CrossRefPubMedGoogle Scholar
  5. 5.
    Marconi M, Nowotny A, Pantke P, Diemer T, Weidner W (2008) Antisperm antibodies detected by MAR and immunobead test are not associated with inflammation and infection of the seminal tract. Andrologia 40:227–234CrossRefPubMedGoogle Scholar
  6. 6.
    Eggert-Kruse W, Rohr G, Böckem-Hellwig S, Huber K, Christmann-Edoga M, Runnebaum B (1995) Immunological aspects of subfertility. Int J Androl 18:43–52PubMedGoogle Scholar
  7. 7.
    Marconi M, Pilatz A, Wagenlehner F, Diemer T, Weidner W (2009) Are really antisperm antibodies associated with inflammatory/infectious diseases of the male reproductive tract. Eur Urol 56:708–715CrossRefPubMedGoogle Scholar
  8. 8.
    Mazumdar S, Levine A (1998) Antisperm antibodies: etiology, pathogenesis, diagnosis, and treatment. Fertil Steril 70:799–810CrossRefPubMedGoogle Scholar
  9. 9.
    Bronson RA, O’Connor WJ, Wilson TA, Bronson SK, Chasalow FI, Droesch K (1992) Correlation between puberty and the development of autoimmunity to spermatozoa in men with cystic fibrosis. Fertil Steril 58:1199–1204CrossRefPubMedGoogle Scholar
  10. 10.
    Boorjian S, Lipkin M, Goldstein M (2004) The impact of obstructive interval and sperm granuloma on outcome of vasectomy reversal. J Urol 171:304–306CrossRefPubMedGoogle Scholar
  11. 11.
    Flickinger CJ, Howards SS, Bush LA, Baker LA, Herr JC (1994) Temporal recognition of sperm autoantigens by IgM and IgG autoantibodies after vasectomy and vasovasostomy. J Reprod Immunol 27:135–150CrossRefPubMedGoogle Scholar
  12. 12.
    Witkin SS, Goldstein M (1988) Reduced levels of T suppressor/cytotoxic lymphocytes in semen from vasovasostomized men: relationship to sperm autoantibodies. J Reprod Immunol 14:283–290CrossRefPubMedGoogle Scholar
  13. 13.
    Dondero F, Lenzi A, Gandini L, Lombardo F (1993) Immunological infertility in humans. Exp Clin Immunogenet 10:65–72PubMedGoogle Scholar
  14. 14.
    Choi YJ, Reiner L (1983) Autoimmune response following vasectomy. N Y State J Med 83:819–822PubMedGoogle Scholar
  15. 15.
    Lenzi A, Gandini L, Claroni F, Dondero F (1987) Post-vasectomy antisperm immune reaction after testosterone-induced azoospermia. Br J Urol 59:277–279CrossRefPubMedGoogle Scholar
  16. 16.
    Wen RQ, Li SQ, Wang CX, Wang QH, Li QK, Feng HM, Jiang YJ, Huang JC (1994) Analysis of spermatozoa from the proximal vas deferens of vasectomized men. Int J Androl 17(4):181–185CrossRefPubMedGoogle Scholar
  17. 17.
    Meinertz H (1991) Antisperm antibodies in split ejaculates. Am J Reprod Immunol 26(3):110–113CrossRefPubMedGoogle Scholar
  18. 18.
    Hoover P, Naz RK (2012) Do men with prostate abnormalities (prostatitis/benign prostatic hyperplasia/prostate cancer) develop immunity to spermatozoa or seminal plasma? Int J Androl 35(4):608–615CrossRefPubMedGoogle Scholar
  19. 19.
    Witkin SS, Toth A (1983) Relationship between genital tract infections, sperm antibodies in seminal fluid and infertility. Fertil Steril 40:805–808CrossRefPubMedGoogle Scholar
  20. 20.
    Jarow JP, Kirkland JA, Assimos DG (1990) Association antisperm antibodies with chronic non bacterial prostatitis. Urology 36:154–156CrossRefPubMedGoogle Scholar
  21. 21.
    Garolla A, Pizzol D, Bertoldo A, De Toni L, Barzon L, Foresta C (2013) Association, prevalence, and clearance of human papillomavirus and antisperm antibodies in infected semen samples from infertile patients. Fertil Steril 99(1):125–131CrossRefPubMedGoogle Scholar
  22. 22.
    Dohle GR (2003) Inflammatory-associated obstructions of the male reproductive tract. Andrologia 35:321–324CrossRefPubMedGoogle Scholar
  23. 23.
    Engeler DS, Hauri D, John H (2003) Impact of prostatitis NIH IIIB (prostatodynia) on ejaculate parameters. Eur Urol 44:546–548CrossRefPubMedGoogle Scholar
  24. 24.
    Weidner W, Anderson RU (2008) Evaluation of acute and chronic bacterial prostatitis and diagnostic management of chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS) with special reference to infection/inflammation. Int J Antimicrob Agents 31:S91–S95CrossRefPubMedGoogle Scholar
  25. 25.
    Dondero F, Radicioni A, Gandini L, Lenzi A (1984) Immunoglobulins in human seminal plasma. Andrologia 16:228–236CrossRefPubMedGoogle Scholar
  26. 26.
    Muñoz MG, Witkin SS (1995) Autoimmunity to spermatozoa, asymptomatic Chlamydia trachomatis genital tract infection and gamma delta T lymphocytes in seminal fluid from the male partners of couples with unexplained infertility. Hum Reprod 10:1070–1074PubMedGoogle Scholar
  27. 27.
    Eggert-Kruse W, Buhlinger-Gopfarth N, Rohr G, Probst S, Aufenanger J, Naher H, Runnebaum B (1996) Antibodies to chlamydia trachomatis in semen and relationship with parameters of male fertility. Hum Reprod 11:1408–1417CrossRefPubMedGoogle Scholar
  28. 28.
    Gil T, Castilla JA, Hortas ML, Redondo M, Samaniego F, Garrido F, Vergara F, Herruzo AJ (1998) Increase of large granular lymphocytes in human ejaculate containing antisperm antibodies. Hum Reprod 13:296–301CrossRefPubMedGoogle Scholar
  29. 29.
    Gonzales GF, Kortebani G, Mazzolli AB (1992) Leukocytospermia and function of the seminal vesicles on seminal quality. Fertil Steril 57:1058–1065CrossRefPubMedGoogle Scholar
  30. 30.
    Kortebani G, Gonzales GF, Barrera C, Mazzolli AB (1992) Leucocyte populations in semen and male accessory gland function: relationship with antisperm antibodies and seminal quality. Andrologia 24:197–204CrossRefPubMedGoogle Scholar
  31. 31.
    Wolff H, Politch JA, Martinez A, Haimovici F, Hill JA, Anderson DJ (1990) Leukocytospermia is associated with poor semen quality. Fertil Steril 53:528–536CrossRefPubMedGoogle Scholar
  32. 32.
    Komori K, Tsujimura A, Miura H, Shin M, Takada T, Honda M, Matsumiya K, Fujioka H (2004) Serial follow-up study of serum testosterone and antisperm antibodies in patients with non-obstructive azoospermia after conventional or microdissection testicular sperm extraction. Int J Androl 27:32–37CrossRefPubMedGoogle Scholar
  33. 33.
    Leonhartsberger N, Gozzi C, Akkad T, Springer-Stoehr B, Bartsch G, Steiner H (2007) Organ-sparing surgery does not lead to greater antisperm antibody levels than orchidectomy. BJU Int 100:371–374CrossRefPubMedGoogle Scholar
  34. 34.
    Abbas AK, Burstein HJ, Bogen SA (1993) Determinants of helper T cell-dependent antibody production. Semin Immunol 5:441–447CrossRefPubMedGoogle Scholar
  35. 35.
    Seiler P, Cooper TG, Nieschlag E (2000) Sperm number and condition affect the number of basal cells and their expression of macrophage antigen in the murine epididymis. Int J Androl 23(2):65–76CrossRefPubMedGoogle Scholar
  36. 36.
    Wolff H, Schill WB (1985) Antisperm antibodies in infertile and homosexual men: relationship to serologic and clinical findings. Fertil Steril 44:673–677CrossRefPubMedGoogle Scholar
  37. 37.
    Barratt CL, Harrison PE, Robinson A, Cooke ID (1990) Antisperm antibodies and lymphocyte subsets in semen–not a simple relationship. Int J Androl 13:50–58CrossRefPubMedGoogle Scholar
  38. 38.
    Dimitrova D, Kalaydjiev S, Hristov L, Nikolov K, Boyadjiev T, Nakov L (2004) Antichlamydial and antisperm antibodies in patients with chlamydial infections. Am J Reprod Immunol 52:330–336CrossRefPubMedGoogle Scholar
  39. 39.
    Eggert-Kruse W, Rohr G, Demirakca T, Rusu R, Näher H, Petzoldt D, Runnebaum B (1997) Chlamydial serology in 1303 asymptomatic subfertile couples. Hum Reprod 12:1464–1475CrossRefPubMedGoogle Scholar
  40. 40.
    Blacklock NJ (1974) Anatomical factors in prostatitis. Br J Urol 46:47–54CrossRefPubMedGoogle Scholar
  41. 41.
    Rumke P, Hellinga G (1959) Autoantibodies against spermatozoa in sterile men. Am J Clin Pathol 32:357–363CrossRefPubMedGoogle Scholar
  42. 42.
    Golomb J, Vardinon N, Homonnai ZT, Braf Z, Yust I (1986) Demonstration of antispermatozoal antibodies in varicocele-related infertility with an enzyme-linked immunosorbent assay (ELISA). Fertil Steril 45:397–402CrossRefPubMedGoogle Scholar
  43. 43.
    Gilbert BR, Witkin SS, Goldstein M (1989) Correlation of sperm-bound immunoglobulins with impaired semen analysis in infertile men with varicoceles. Fertil Steril 52:469–473CrossRefPubMedGoogle Scholar
  44. 44.
    Isitmangil G, Yildirim S, Orhan I, Kadioglu A, Akinci M (1999) A comparison of the sperm mixed-agglutination reaction test with the peroxidase-labelled protein A test for detecting antisperm antibodies in infertile men with varicocele. BJU Int 84:835–838CrossRefPubMedGoogle Scholar
  45. 45.
    Knudson G, Ross L, Stuhldreher D, Houlihan D, Bruns E, Prins G (1994) Prevalence of sperm bound antibodies in infertile men with varicocele: the effect of varicocele ligation on antibody levels and semen response. J Urol 151:1260–1262PubMedGoogle Scholar
  46. 46.
    Djaladat H, Mehrsai A, Rezazade M, Djaladat Y, Pourmand G (2006) Varicocele and anti-sperm antibody: fact or fiction? South Med J 99:44–47CrossRefPubMedGoogle Scholar
  47. 47.
    Bozhedomov VA, Lipatova NA, Alexeev RA, Alexandrova LM, Nikolaeva MA, Sukhikh GT (2014) The role of the antisperm antibodies in male infertility assessment after microsurgical varicocelectomy. Andrology 2(6):847–855CrossRefPubMedGoogle Scholar
  48. 48.
    Oshinsky GS, Rodriguez MV, Mellinger BC (1993) Varicocele-related infertility is not associated with increased sperm-bound antibody. J Urol 150:871–873PubMedGoogle Scholar
  49. 49.
    Heidenreich A, Bonfig R, Wilbert DM, Strohmaier WL, Engelmann UH (1994) Risk factors for antisperm antibodies in infertile men. Am J Reprod Immunol 31:69CrossRefPubMedGoogle Scholar
  50. 50.
    Veräjänkorva E, Laato M, Pöllänen P (2003) Analysis of 508 infertile male patients in south-western Finland in 1980–2000: hormonal status and factors predisposing to immunological infertility. Eur J Obstet Gynecol Reprod Biol 10:173–178CrossRefGoogle Scholar
  51. 51.
    Bozhedomov VA, Lipatova NA, Rokhlikov IM, Alexeev RA, Ushakova IV, Sukhikh GT (2014) Male fertility and varicocele: role of immune factors. Andrology 2:51–58CrossRefPubMedGoogle Scholar
  52. 52.
    Shook TE, Nyberg LM, Collins BS, Mathur S (1988) Pathological and immunological effects of surgically induced varicocele in juvenile and adult rats. Am J Reprod Immunol Microbiol 17:141–144CrossRefPubMedGoogle Scholar
  53. 53.
    Turner TT, Jones CE, Roddy MS (1987) Experimental varicocele does not affect the blood–testis barrier, epididymal electrolyte concentrations, or testicular blood gas concentrations. Biol Reprod 36:926–931CrossRefPubMedGoogle Scholar
  54. 54.
    Trussell JC, Lee PA (2004) The relationship of cryptorchidism to fertility. Curr Urol Rep 5:142–148CrossRefPubMedGoogle Scholar
  55. 55.
    Sinisi AA, Pasquali D, Papparella A, Valente A, Orio F, Esposito D, Cobellis G, Cuomo A, Angelone G, Martone A, Fioretti GP, Bellastella A (1998) Antisperm antibodies in cryptorchidism before and after surgery. J Urol 160:1834–1837CrossRefPubMedGoogle Scholar
  56. 56.
    Urry RL, Carrell DT, Starr NT, Snow BW, Middleton RG (1994) The incidence of antisperm antibodies in infertility patients with a history of cryptorchidism. J Urol 151:381–383PubMedGoogle Scholar
  57. 57.
    Jiang H, Zhu WJ (2013) Cryptorchidism is not a risk factor for antisperm antibody production in post-orchidopexy males with infertility. Urol Int 90(4):470–474CrossRefPubMedGoogle Scholar
  58. 58.
    Cortes D, Brandt B, Thorup J (1990) Direct mixed antiglobulin reaction (MAR) test in semen at follow-up after testicular biopsy of maldescended testes operated in puberty. Z Kinderchir 45:227–228PubMedGoogle Scholar
  59. 59.
    Patel RP, Kolon TF, Huff DS, Carr MC, Zderic SA, Canning DA, Snyder HM 3rd (2005) Testicular microlithiasis and antisperm antibodies following testicular biopsy in boys with cryptorchidism. J Urol 174:2008–2010CrossRefPubMedGoogle Scholar
  60. 60.
    Mirilas P, Mamoulakis C, De Almeida M (2003) Puberty does not induce serum antisperm surface antibodies in patients with previously operated cryptorchidism. J Urol 170:2432–2435CrossRefPubMedGoogle Scholar
  61. 61.
    Mirilas P, De Almeida M (1999) Absence of antisperm surface antibodies in prepubertal boys with cryptorchidism and other anomalies of the inguinoscrotal region before and after surgery. J Urol 162:177–181CrossRefPubMedGoogle Scholar
  62. 62.
    Lenzi A, Gandini L, Lombardo F, Cappa M, Nardini P, Ferro F, Borrelli P, Dondero F (1991) Antisperm antibodies in young boys. Andrologia 23:233–235CrossRefPubMedGoogle Scholar
  63. 63.
    Mininberg DT, Chen ME, Witkin SS (1993) Antisperm antibodies in cryptorchid boys. Eur J Pediatr 152(Suppl 2):S23–S24CrossRefPubMedGoogle Scholar
  64. 64.
    Sinisi AA, D’Apuzzo A, Pasquali D, Venditto T, Esposito D, Pisano G, De Bellis A, Ventre I, Papparella A, Perrone L, Bellastella A (1997) Antisperm antibodies in prepubertal boys treated with chemotherapy for malignant or non-malignant diseases and in boys with genital tract abnormalities. Int J Androl 20:23–28CrossRefPubMedGoogle Scholar
  65. 65.
    Hagenäs L, Plöen L, Ritzen EM, Ekwall H (1977) Blood-testis barrier: maintained function of inter-Sertoli cell junctions in experimental cryptorchidism in the rat, as judged by a simple lanthanum-immersion technique. Andrologia 9:250–254CrossRefPubMedGoogle Scholar
  66. 66.
    Stewart RJ, Boyd S, Brown S, Toner PG (1990) The blood–testis barrier in experimental unilateral cryptorchidism. J Pathol 160:51–55CrossRefPubMedGoogle Scholar
  67. 67.
    Kukadia AN, Ercole CJ, Gleich P, Hensleigh H, Pryor JL (1996) Testicular trauma: potential impact on reproductive function. J Urol 156:1643–1646CrossRefPubMedGoogle Scholar
  68. 68.
    Ozturk U, Ozdemir E, Dede O, Sagnak L, Goktug HN (2011) Assessment of anti-sperm antibodies in couples after testicular sperm extraction. Clin Invest Med 34(3):E179–E183PubMedGoogle Scholar
  69. 69.
    Harrington TG, Schauer D, Gilbert BR (1996) Percutaneous testis biopsy: an alternative to open testicular biopsy in the evaluation of the subfertile man. J Urol 156:1647–1651CrossRefPubMedGoogle Scholar
  70. 70.
    Stula I, Druzijanic N, Sapunar A, Perko Z, Bosnjak N, Kraljevic D (2014) Antisperm antibodies and testicular blood flow after inguinal hernia mesh repair. Surg Endosc 28(12):3413–3420CrossRefPubMedGoogle Scholar
  71. 71.
    Lievano G, Nguyen L, Radhakrishnan J, Fornell L, John E (1999) New animal model to evaluate testicular blood flow during testicular torsion. J Pediatr Surg 34:1004–1006CrossRefPubMedGoogle Scholar
  72. 72.
    Arap MA, Vicentini FC, Cocuzza M, Hallak J, Athayde K, Lucon AM, Arap S, Srougi M (2007) Late hormonal levels, semen parameters, and presence of antisperm antibodies in patients treated for testicular torsion. J Androl 28:528–532CrossRefPubMedGoogle Scholar
  73. 73.
    Anderson MJ, Dunn JK, Lipshultz LI, Coburn M (1992) Semen quality and endocrine parameters after acute testicular torsion. J Urol 147:1545–1550PubMedGoogle Scholar
  74. 74.
    Koşar A, Küpeli B, Alçigir G, Ataoglu H, Sarica K, Küpeli S (1999) Immunologic aspect of testicular torsion: detection of antisperm antibodies in contralateral testicle. Eur Urol 36:640–644CrossRefPubMedGoogle Scholar
  75. 75.
    Foster RS, Rubin LR, McNulty A, Bihrle R, Donohue JP (1991) Detection of antisperm-antibodies in patients with primary testicular cancer. Int J Androl 14:179–185CrossRefPubMedGoogle Scholar
  76. 76.
    Guazzieri S, Lembo A, Ferro G, Artibani W, Merlo F, Zanchetta R, Pagano F (1985) Sperm antibodies and infertility in patients with testicular cancer. Urology 26:139–142CrossRefPubMedGoogle Scholar
  77. 77.
    Höbarth K, Klingler HC, Maier U, Kollaritsch H (1994) Incidence of antisperm antibodies in patients with carcinoma of the testis and in subfertile men with normogonadotropic oligoasthenoteratozoospermia. Urol Int 52:162–165CrossRefPubMedGoogle Scholar
  78. 78.
    Paoli D, Gilio B, Piroli E, Gallo M, Lombardo F, Dondero F, Lenzi A, Gandini L (2009) Testicular tumors as a possible cause of antisperm autoimmune response. Fertil Steril 91(2):414–419CrossRefPubMedGoogle Scholar
  79. 79.
    Jiang H, Zhu WJ (2013) Testicular microlithiasis is not a risk factor for the production of antisperm antibody in infertile males. Andrologia 45:305–309CrossRefPubMedGoogle Scholar
  80. 80.
    Richards JM, Bedford JM, Witkin SS (1984) Rectal insemination modifies immune responses in rabbits. Science 27:390–392CrossRefGoogle Scholar
  81. 81.
    Witkin SS, Sonnabend J, Richards JM, Purtilo DT (1983) Induction of antibody to asialo GM1 by spermatozoa and its occurrence in the sera of homosexual men with the acquired immune deficiency syndrome (AIDS). Clin Exp Immunol 54:346–350PubMedPubMedCentralGoogle Scholar
  82. 82.
    Mulhall BP, Fieldhouse S, Clark S, Carter L, Harrison L, Donovan B, Short RV (1990) Anti-sperm antibodies in homosexual men: prevalence and correlation with sexual behaviour. Genitourin Med 66:5–7PubMedPubMedCentralGoogle Scholar
  83. 83.
    Sands M, Phair JP, Hyprikar J, Hansen C, Brown RB (1985) A study on antisperm antibody in homosexual men. J Med 16:483–491PubMedGoogle Scholar

Copyright information

© Springer International Publishing Switzerland 2017

Authors and Affiliations

  1. 1.Department of Urology, Faculty of MedicinePontificia Universidad Catolica de ChileSantiagoChile
  2. 2.Department of Urology and Pediatric UrologyUniversity Hospital Giessen and Marburg GmbH – Giessen, Justus-Liebig-UniversitätGiessenGermany

Personalised recommendations